These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 213626)

  • 1. [Kinin-system and kidney function].
    Komori T; Okahara T; Abe Y; Yamamoto K
    Nihon Rinsho; 1978 Aug; 36(8):2899-904. PubMed ID: 213626
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation and mediation of the action of the renal kallikrein-kinin system by prostaglandins.
    McGiff JC; Itskovitz HD; Terragno A; Wong PY
    Fed Proc; 1976 Feb; 35(2):175-80. PubMed ID: 765161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and function of kinins.
    Eisen V
    Rheumatology; 1970; 3():103-68. PubMed ID: 4945765
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
    Shimamoto K; Matsuki T; Iimura O
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal kinin-prostaglandin relationship: implications for renal function.
    Nasjletti A; Malik KU
    Kidney Int; 1981 Jun; 19(6):860-8. PubMed ID: 6167754
    [No Abstract]   [Full Text] [Related]  

  • 6. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
    Nasjletti A; Colina-Chourio J; McGiff JC
    Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of mineralocorticoids, renal prostaglandins and the renal kallikrein-kinin system.
    Nasjletti A; Colina-Chourio J
    Fed Proc; 1976 Feb; 35(2):189-93. PubMed ID: 765163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The kallikrein-kinin system and blood pressure regulation].
    Yasujima M; Abe K
    Nihon Rinsho; 1989 Sep; 47(9):1956-62. PubMed ID: 2593269
    [No Abstract]   [Full Text] [Related]  

  • 11. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
    Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
    Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renal kallikrein-kinin and prostaglandin systems interaction.
    Nasjletti A; Malik KU
    Annu Rev Physiol; 1981; 43():597-609. PubMed ID: 7011201
    [No Abstract]   [Full Text] [Related]  

  • 14. Converting enzyme inhibitors and the interaction between kinins and eicosanoids.
    Schrör K
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S60-8. PubMed ID: 1697363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinins paracrine hormone.
    Carretero OA; Scicli AG
    Kidney Int Suppl; 1988 Oct; 26():S52-9. PubMed ID: 3059033
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspects of plasma kinin physiology.
    Amundsen E
    Scand J Clin Lab Invest Suppl; 1969; 107():65-71. PubMed ID: 5375729
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The kallikrein-kinin system and kidney function].
    Gŭrchev R; Avramova T
    Eksp Med Morfol; 1988; 27(1):61-7. PubMed ID: 3286220
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacology of the kallikrein-kinin system].
    Shimamoto K; Nishitani T; Iimura O
    Nihon Rinsho; 1985 May; 43(5):964-70. PubMed ID: 2993707
    [No Abstract]   [Full Text] [Related]  

  • 20. Hageman factor dependent activation and its relationship to lethal Pseudomonas aeruginosa burn wound infections.
    Holder IA; Neely AN
    Agents Actions Suppl; 1992; 38 ( Pt 3)():329-42. PubMed ID: 1462867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.